Insider Selling: HealthEquity, Inc. (NASDAQ:HQY) Director Sells $684,585.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

HealthEquity Trading Up 0.8 %

Shares of HQY stock opened at $85.42 on Monday. HealthEquity, Inc. has a 12-month low of $61.81 and a 12-month high of $88.26. The firm has a 50 day moving average price of $77.14 and a two-hundred day moving average price of $79.28. The company has a market capitalization of $7.43 billion, a PE ratio of 92.85, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. The business had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Wells Fargo & Company upped their price objective on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a report on Thursday, June 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America reduced their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $103.83.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Forest Hill Capital LLC purchased a new stake in HealthEquity in the 4th quarter valued at about $2,021,000. Goldman Sachs Group Inc. grew its position in shares of HealthEquity by 24.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,129,634 shares of the company’s stock valued at $74,895,000 after acquiring an additional 223,428 shares during the period. Vanguard Group Inc. grew its position in shares of HealthEquity by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 8,619,499 shares of the company’s stock valued at $571,473,000 after acquiring an additional 104,084 shares during the period. Kapitalo Investimentos Ltda bought a new position in shares of HealthEquity during the 4th quarter valued at approximately $147,000. Finally, Rise Advisors LLC bought a new position in shares of HealthEquity during the 1st quarter valued at approximately $28,000. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.